Disparities in HIV Care - Special Edition of eHIV Review to Address this Urgent Topic

Disparities in HIV Care - Special Edition of eHIV Review to Address this Urgent Topic
Contact: Matt Miller
Phone: 646-336-6495
Fax: 646-336-6497
Email: [email protected]

NEW YORK (12/5/2023) – DKBmed, LLC, in collaboration with the Johns Hopkins School of Medicine, has launched a special edition of its popular eHIV Review series. This special edition, consisting of a newsletter and paired podcast, will focus on barriers to care and the unique needs of underserved populations with or at risk of contracting HIV, with expert discussion on how new and emerging therapies and integrated care may improve outcomes in these populations.

This program can be found at: eHIVReview.org

With currently available medications, individuals with HIV now have a greater life expectancy and those with a suppressed viral load cannot transmit HIV to others. But not all people living with HIV have the same access to HIV care or the same ability to remain in care. Traditionally marginalized populations — such as formerly incarcerated individuals, people with unstable housing, immigrant populations, those with substance use disorder, and residents of rural communities — face particularly challenging barriers to initiation and retention in care. Given these challenges, there is an urgent need to provide meaningful and culturally sensitive care to improve entry into the continuum of care in these underserved communities.

“The US public health system aims to end the HIV epidemic by 2030,” notes Justin Alves, RN, ACRN, CARN, Nurse Educator at Boston Medical Center and eHIV Review Program Director. “We can’t do that without overcoming the barriers that prevent the highly successful tools and treatments we currently have from reaching all people, including those from marginalized populations, who face the greatest barriers to inclusion in the HIV care continuum.”

By exploring the latest clinical information on HIV and PrEP through interviews with expert faculty discussing new developments and re-engagement in care, this special edition of eHIV Review will refocus and refresh clinicians on HIV and PrEP in the wake of the COVID-19 pandemic.

Success of eHIV Review

This special edition comes after the success of the previous seven volumes, which are designed to increase clinicians’ confidence and knowledge about preventing, diagnosing, and managing HIV. Approximately 88% of participants rated eHIV Review highly, with 93% of clinicians agreeing that their medical practice knowledge improved. To date, eHIV Review Review has more than 8,600 subscribers, and viewership continues to grow.

Disclosure of Support

This Special Edition of eHIV Review is supported by an independent educational grant provided by ViiV Healthcare.

About DKBmed

DKBmed is an integrated continuing medical education company operated by a team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

Working with accredited providers, DKBmed develops innovative educational programs and quality improvement (QI) initiatives and specializes in bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in pain management, HIV, depression, and diabetic retinopathy. DKBmed was also an early adopter of case scenarios with recorded and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, e-mail, and mobile phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn using state-of-the-art techniques and access educational programs in a manner that is most convenient and appropriate for them.

DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.